HealthRX.com · Printable lab tracker
EGRIFTA with levothyroxine: thyroid results and what changed
Record why you take levothyroxine, your pituitary history, and each TSH or free T4 result next to anything that changed at the time, so a new result can be read against the levothyroxine label's own rules before anyone blames EGRIFTA.
Why you take levothyroxine
Kind of hypothyroidismprimary, secondary (pituitary), tertiary (hypothalamic), after thyroid surgery or treatment, not sure
Product, strength and who makes it
When and how you take ittime, empty stomach or not, what you take near it
Any pituitary surgery or tumor, head radiation or head injury
Your EGRIFTA
ProductEGRIFTA WR or EGRIFTA SV
Date started
Prescriber
Thyroid results next to what changed
| Date drawn | TSH | Free T4 | Levothyroxine dose then | Weeks since last dose change | Anything new: calcium, iron, antacid, PPI, biotin, illness | How you felt |
|---|---|---|---|---|---|---|
What the two labels say
- EGRIFTA trials showed no clinically significant change in TSH or other pituitary hormones.[1]
- EGRIFTA is contraindicated with disruption of the hypothalamic-pituitary axis from hypophysectomy, hypopituitarism, pituitary tumor or surgery, head irradiation or head trauma.[1]
- Primary hypothyroidism: TSH 6 to 8 weeks after any levothyroxine dose change, then every 6 to 12 months while stable.[2]
- Secondary or tertiary hypothyroidism: TSH is not a reliable guide to the levothyroxine dose.[2]
- Keep levothyroxine at least 4 hours apart from medicines that interfere with its absorption.[2]
- Stop biotin supplements at least 2 days before a TSH or T4 test.[2]
For the prescriber or endocrinologist
- Which kind of hypothyroidism do I have, and should we follow TSH or free T4?
- Does anything in my pituitary history matter for EGRIFTA?
- Is a thyroid test due anyway, regardless of EGRIFTA?
- If a result changes, what else should we rule out before changing my dose?
- Should I keep my levothyroxine routine exactly as it is?
Sources for the facts on this sheet
- Theratechnologies Inc., via DailyMed. EGRIFTA WR (tesamorelin) for injection, for subcutaneous use: prescribing information, patient information and instructions for use. Effective 2026-07-29. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75
- RemedyRepack Inc., via DailyMed. Levothyroxine sodium tablets, for oral use: prescribing information. Effective 2026-04-06. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7d5b71b-e983-4b1a-bfc2-d2343cf8668c
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.